ConMed reported 3Q19 revenue of USD $110.3MM, +7.2% vs. 3Q18.
ConMed updated full year 2019 revenue guidance to the range of $951.3MM (+10.7%) to $956.6MM (+11.3%) Growth driven by continuity of leadership and new products integrated with training and education programs Recurring, single-use products comprise 70% of the company’s orthopedic revenue ORTHOWORLD projects ConMed sports medicine full year 2019 revenue of $466.9MM, +4.5% vs. 2018 ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM).
3Q19 3Q18 $ Chg % Chg Sports Medicine $110.3 $102.9 $7.4 7.2%
9Mo 19 9Mo 18 $ Chg % Chg Sports Medicine $339.5 $321.9 $17.6 5.5%
ORTHOWORLD estimates orthopedic sales by geographic region as follows ($MM).
3Q19 3Q18 $ Chg % Chg U.S. $42.5 $39.6 $3.0 7.5% Ex-U.S. $67.8 $63.4 $4.4 7% EMEA $24.7 $23.2 $1.5 6.4% Asia Pacific $26.0 $25.2 $0.8 3.3% Rest of World $17.1 $14.9 $2.1 14.2% Total $110.3 $102.9 $7.4 7.2%
Net earnings, inclusive of all ConMed revenue, are as follows ($MM).
Amt % of Sales Sales $233.6 Cost of Sales ($103.5) 44.3% Selling and Admin ($98.2) 42% R&D ($11.0) 4.7% Other ($14.0) 6% Net Earnings $7.0 3%
Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email .
Favorite
ConMed reported 3Q19 revenue of USD $110.3MM, +7.2% vs. 3Q18.
ConMed updated full year 2019 revenue guidance to the range of $951.3MM (+10.7%) to $956.6MM (+11.3%)
ConMed reported 3Q19 revenue of USD $110.3MM, +7.2% vs. 3Q18.
ConMed updated full year 2019 revenue guidance to the range of $951.3MM (+10.7%) to $956.6MM (+11.3%) Growth driven by continuity of leadership and new products integrated with training and education programs Recurring, single-use products comprise 70% of the company’s orthopedic revenue ORTHOWORLD projects ConMed sports medicine full year 2019 revenue of $466.9MM, +4.5% vs. 2018 ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM).
3Q19 3Q18 $ Chg % Chg Sports Medicine $110.3 $102.9 $7.4 7.2%
9Mo 19 9Mo 18 $ Chg % Chg Sports Medicine $339.5 $321.9 $17.6 5.5%
ORTHOWORLD estimates orthopedic sales by geographic region as follows ($MM).
3Q19 3Q18 $ Chg % Chg U.S. $42.5 $39.6 $3.0 7.5% Ex-U.S. $67.8 $63.4 $4.4 7% EMEA $24.7 $23.2 $1.5 6.4% Asia Pacific $26.0 $25.2 $0.8 3.3% Rest of World $17.1 $14.9 $2.1 14.2% Total $110.3 $102.9 $7.4 7.2%
Net earnings, inclusive of all ConMed revenue, are as follows ($MM).
Amt % of Sales Sales $233.6 Cost of Sales ($103.5) 44.3% Selling and Admin ($98.2) 42% R&D ($11.0) 4.7% Other ($14.0) 6% Net Earnings $7.0 3%
Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email .
Favorite You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
